CompletedNot Applicable

Pneumocystis Primary Infection in Non-immunosuppressed Infants

France400 participantsStarted 2019-01-21

Plain-language summary

To determine the prevalence of P. jirovecii in nasopharyngeal aspirations of neonates and infants hospitalized for symptomatic respiratory infection.

Who can participate

Age range12 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * symptomatic newborns and infants who underwent NPAs for microbiological diagnoses Exclusion Criteria: * asymptomatic newborns and infants, newborns and infants who did not undergo NPAs, infants \> 12 months or children \> 2 years; newborns and infants whose parents did not accept to participate

What they're measuring

Pneumocystis presence or not in nasopharyngeal specimens from newborns and infants

Timeframe: At patient inclusion

Trial details

NCT IDNCT03740646

SponsorUniversity Hospital, Brest

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-05-31

View on ClinicalTrials.gov More Pulmonary Diseases trials